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IFN-γ-producing CD4+ T (Th1) cells and IL-17-producing CD4+ T (Th17) cells play a criti-
cal role in the pathogenesis of chronic obstructive pulmonary disease (COPD). However, 
the immune regulation between Th1 and Th17 cells remains unclear. Previous studies 
have demonstrated that interleukin-27 (IL-27)/WSX-1 exerted pro- or anti-inflammatory 
effects in many acute inflammatory diseases by modulating T cell-mediated immune 
response, but little was known about its role in chronic inflammatory disease, espe-
cially in smoking-related lung diseases. Considering IL-27 is an important regulator in 
T lymphocytes immune responses and was found markedly increased in patients with 
COPD, we hypothesized that IL-27/WSX-1 may exert immuno-regulatory effects on the 
differentiation of Th1 and Th17 cells in smoking-related COPD. In this study, we aimed 
to evaluate the expression of IL-27 in patients with COPD and explore the role of IL-27/
WSX-1 on Th1 and Th17 cells differentiation in a smoking mouse model of emphysema. 
We found that elevated expression of IL-27 was associated with increased proportion 
of Th1 cells and Th17 cells in patients with COPD and demonstrated parallel findings in 
cigarette smoke-exposed mice. In addition, cigarette smoke exposure upregulated the 
expression of IL-27R (WSX-1) by naive CD4+ T cells in mice. In vitro, IL-27 significantly 
augmented the secretion of IFN-γ by naive CD4+ T cells via a T-bet, p-STAT1, and 
p-STAT3-dependent manner, but inhibited the production of IL-17 by a ROR-γt and 
p-STAT1-dependent way. Furthermore, anti-IL27 treatment dramatically decreased the 
expression of IFN-γ-producing CD4+ T cells in cigarette smoke-exposed mice. These 
findings proposed that IL-27 has functions for promoting the expression of Th1 cells 
but inhibiting the expression of Th17 cells in vitro and IL-27 neutralization-attenuated 
Th1-mediated inflammation in  vivo, suggesting targeting IL-27/WSX-1 may provide a 
new therapeutic approach for smoking-related COPD.
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0 (0) 20 (0) 16 (22)
FEV 1, l 2.7 ± 0.3 2.6 ± 0.3 1.2 ± 0.2a,b
FVC, l 3.3 ± 0.4 3.4 ± 0.3 2.7 ± 0.5c,d
FEV1 (% pred) 97.0 ± 5.2 96.9 ± 4.3 41.7 ± 5.6e,f
FEV 1/FVC, % 80.6 ± 4.1 76.9 ± 3.4 46.9 ± 6.1g,h
Taking inhaled steroids 0 0 0
Data are expressed as means ± SD; statistical analysis was performed with one-way 
ANOVA.
M, male; F, female; FEV1 (% pred), forced expiratory volume in 1 s (% of predicted).
a,c,e,gp < 0.05 when compared with non-smokers.
b,d,f,hp < 0.05 when compared with healthy smokers.
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inTrODUcTiOn
Chronic obstructive pulmonary disease (COPD) is character-
ized by chronic airway inflammation and destruction of lung 
parenchyma. Tobacco smoking is recognized as the most 
important risk factor for COPD. Despite increased awareness 
and concerns of smoking hazards in general population, the 
global burden of smoking-related lung diseases (e.g., COPD, 
chronic bronchitis, and lung cancer) continues to increase in 
worldwide. Large studies have demonstrated that the mortal-
ity among smokers who began to smoke in early adult life and 
did not quit was two to three times the mortality among those 
who never smoked, leading to a reduction in life span by an 
average of about 10  years (1–5). Although COPD is expected 
to become the third leading cause of death worldwide by 2020 
and imposes a heavy burden on health-care systems, the precise 
pathogenesis of smoking-related COPD has not yet been fully 
elucidated. It has been well established that COPD exhibited a 
predominant IFN-γ-producing T (Th1/Tc1) cell cytokine pat-
tern (6–8). Interestingly, Th1 cells are generally in association 
with IL-17-producing CD4+ T helper (Th17) cells in the context 
of infectious or some autoimmune diseases, such as experimen-
tal autoimmune encephalitis (EAE), collagen-induced arthritis 
(CIA), and inflammatory bowel disease (IBD), which typically 
with Th1-mediated pathogenesis. In our recent studies and with 
others, data revealed that Th17 cells were also exaggerated in 
COPD (9–11). However, relatively little is known about the 
regulatory mechanism between Th1 and Th17 cells.
Interleukin-27 (IL-27) is a heterodimeric cytokine composed 
of EBI3 and p28 and produced mainly by activated antigen-
presenting cells (APCs), such as macrophages and dendritic cells 
(12). IL-27 binds to a receptor complex called IL-27R, which 
is composed of WSX-1 and gp130 (13). Despite the expression 
of gp130 is widely on various immune and non-immune cells, 
WSX-1 is more confined to immune cells such as T cell, B cell, 
and NK cell. IL-27 not only exerts pro-inflammatory activity by 
enhancing Th1 response but also has potential anti-inflammatory 
function able to regulate excessive Th1 response via increasing the 
production of IL-10 by Th1 cells and inhibition of IL-2 secretion 
(14–19). Aside from the effects on Th1 cells, IL-27 has recently 
reported that played a regulatory role in limiting excessive inflam-
mation during infection with Toxoplasma gondii by modulating 
the development of Th17 cells (20, 21). Moreover, recent studies 
proposed a pivotal role of IL-27 in enhancing regulatory T cells 
(Tregs) function to control T cell-induced colitis, a model for IBD 
in humans (18, 22). Although IL-27/WSX-1 has been found to 
participate in many acute inflammatory diseases such as bacterial 
and parasitic infections, but very little information was available 
concerning its involvement in chronic inflammatory disease, 
especially in smoking-related lung diseases. More recently, Cao 
et  al. reported that IL-27 was elevated in patients with COPD 
and IL-27 level in Sputum was correlated negatively with FEV1 
(% pred), suggesting a critical role of IL-27 in the pathogenesis of 
COPD (23). Given IL-27 is an important regulator in T lympho-
cytes immune responses and was found markedly increased in 
patients with COPD, it is reasonable to predict IL-27/WSX-1 may 
involve in the immune regulation of Th1 and Th17 cells in COPD. 
In the present study, we sought to evaluate the expression of IL-27 
and Th1/Th17 cells in patients with COPD and then explore the 
role of IL-27/WSX-1 on Th1 and Th17 cells differentiation in a 
smoking mouse model of emphysema.
MaTerials anD MeThODs
subjects
Thirty-eight patients with stable COPD, 20 healthy smokers, and 
20 healthy non-smoking control subjects were enrolled in this 
study. COPD patients were diagnosed according to the criteria 
as defined by the Global Initiative for Chronic Obstructive Lung 
Disease (GOLD), were with a smoking history of at least 10 pack-
years. Patients with COPD who had an acute exacerbation for 
4 weeks before enrollment were excluded. Patients who received 
systemic corticosteroids, leukotriene antagonists, or antihista-
mines within the month prior to the study were also excluded. 
This study was approved by the Medical Ethical Committee 
of the First Affiliated Hospital of Guangxi Medical University 
(Nanning, China) and the Medical Ethical Committee of the 
Eighth People’s Hospital of Nanning (Nanning, China), and writ-
ten informed consent was obtained from all participants. Clinical 
characteristics of patients with COPD and control subjects are 
presented in Table 1.
human blood sample collection  
and Processing
Ten milliliters of venous blood were collected from each subject, 
and serum was isolated by centrifugation for 15 min at 800 × g 
and stored at −80°C immediately until analysis. To obtain periph-
eral blood mononuclear cells (PBMCs), blood samples were 
anti-coagulated with heparin and separated by Ficoll-Hypaque 
gradient centrifugation. Fresh isolated PBMCs were kept on ice 
and used for flow cytometric analysis within 1 h.
animals and cigarette smoke exposure
Male BALB/c mice (8 weeks of age, 20–25 g body weight) were 
purchased from the Guangxi Medical University Laboratory 
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Animal Center (Nanning, China). All mice were housed in steri-
lized cages and maintained on a 12:12-h light–dark environment 
and received sterilized diet and water ad libitum. All animal stud-
ies were approved by the Laboratory Animal Ethics Committee of 
Guangxi Medical University.
Mice were exposed to cigarette smoke, as described previously 
(11). Briefly, mice were exposed to five cigarettes (Nanning zhen-
long unfiltered cigarettes: 12 mg of tar and 0.9 mg of nicotine) four 
times a day with 30-min smoke-free intervals in a closed 0.75-m3 
room, 5 days a week, for 24 weeks. Mice tolerated cigarette smoke 
exposure without evidence of toxicity (carboxyhemoglobin levels 
~10% and no weight loss). The control groups were exposed to 
air for 24 weeks. The mice were sacrificed 24 h after the last air or 
smoke exposure.
Mouse sample collection and Processing
Twenty-four hours after the last exposure, mice were anesthetized 
with pentobarbital. Blood samples were collected via retro-orbital 
bleeding. Approximately 300 μl of peripheral blood was collected 
for separate serum after centrifugation (800 ×  g, 15  min), and 
serum was frozen at −80°C immediately for determination of 
the concentration of cytokines. The remaining blood was col-
lected in EDTA-treated tubes and was divided into two parts. 
Approximately 100 μl of peripheral blood was removed via eryth-
rocytes with RBC lysis solution for 10 min at room temperature 
and then washed twice with cold PBS by centrifuged at 300 × g 
for 10  min. The remaining cells were collected for isolation of 
total RNA. PBMCs were isolated by Ficoll-Hypaque gradient 
centrifugation for flow cytometry.
In order to obtain spleen cells suspension, spleens were 
removed and cut into small pieces and were subsequently ground 
gently into single-cell and filtered through nylon mesh. The cell 
suspension was centrifuged at 300 × g for 10 min at 4°C. After 
that, the erythrocytes of cells suspension were removed, as 
described previously, and the cell pellets of spleen were washed 
twice with cold PBS.
Lung single-cell suspensions were isolated by modifying 
established protocols, using a combination of mechanical frag-
mentation, enzyme digestion, and centrifugation procedures, as 
described previously (8, 24). Briefly, lungs were flushed via the 
right ventricle with a needle and the pulmonary circulation was 
perfused with 10 ml of PBS to remove the intravascular pool of 
cells. The lungs were then thoroughly minced and followed by a 
30- to 45-min digestion at 37°C with 1 mg/ml collagenase type IV 
(Sigma-Aldrich) in RPMI 1640 medium. To improve tissue dis-
integration, lungs were incubated in a shaker and pipetted every 
15 min. Subsequently, the lung pieces were triturated through a 
metal screen into PBS with a plunger from a 5-ml syringe, and 
the resulting cell suspension was filtered through a 70-μm cell 
strainer, washed, and lung mononuclear cells were isolated by 
Ficoll-Hypaque gradient centrifugation. The cell suspension was 
then resuspended in PBS and kept on ice until labeling.
histology and Morphometry assay
The lungs were fixed with 10% formalin, embedded in paraffin, 
cut sagittally into 5-μm sections, and stained with hematoxylin 
and eosin (H&E) for histological analysis. We examined the 
enlargement of alveolar spaces by quantifying the mean linear 
intercept (Lm), as described previously. For each animal, 10 fields 
at a magnification of 200× were captured randomly from the 
four different zones of the lung. Two investigators blinded to the 
exposure status independently measured Lm. Two investigators 
independently measured Lm in a blinded manner.
Flow cytometry
The expression markers on T cells from PBMC, spleen, and 
lung were determined by flow cytometry using the following 
antibodies: PerCP-CD4, PE-CD62L, APC-CD44, FITC-IL27R 
(WSX-1), PE-IL17, and APC-IFN-γ, which were purchased 
from BD Pharmingen (San Diego, CA, USA) or R&D systems 
(Minneapolis, MN, USA). Cell surface staining was performed 
according to the standard procedures. For intracellular detection 
of cytokines, cells were stimulated with phorbol-myristate-
acetate (PMA, 25  ng/ml; Sigma-Aldrich) and ionomycin 
(1 ng/ml; Sigma-Aldrich) in the presence of GolgiPlug™ (BD 
Pharmingen) for 4  h at 37°C in 5% CO2. The cells were then 
washed and stained with fluorescent antibodies against CD4 and 
IL27R (WSX-1) at room temperature in the dark. After surface 
staining, cells were fixed/permeabilized in fixation/permeabili-
zation solution (Cytofix/Cytoperm™; BD Pharmingen) accord-
ing to the manufacturer’s protocol, and stained with anti-IFN-γ 
and -IL-17 mAbs for 30  min at 4°C. Cells were then washed 
with Perm/Wash Buffer (BD Pharmingen) and resuspended 
in PBS +2% FBS for flow cytometric analysis. Flow cytometry 
was performed on a BD FACS Canto II (BD Biosciences) and 
analyzed using FCS Express 4 software (De Novo Software, Los 
Angeles, CA, USA).
real-time Quantitative Pcr
For quantifying the relative transcript abundance of IL-27 
(EBI3 and p28), total RNA was extracted from peripheral 
blood, spleens, and lung samples with TRIzol (Invitrogen, Life 
Technologies) according to the manufacturer’s instructions. 
cDNA was prepared using oligo(dT) primers (PrimeScript™RT 
reagent Kit, TAKALA). Quantitative RT-PCR was performed 
by duplicate with SYBR Green I (SYBR®Premix Ex Taq™, 
TAKALA) using an Applied Biosystems 7500 (ThermoFisher 
SCIENTIFIC) according to the manufacturer’s instructions. 
DNA was amplified under the following conditions: dena-
turation at 95°C for 30 s, extension at 95°C for 5 s, 60°C for 34 s, 
and the samples were amplified for 40 cycles. The following 
primers were used: 5′-TGTGTCCGTCGTGGATCTGA-3′, 
5′-TTGCTGTTGAAGTCGCAGGAG-3′ for GAPDH; 5′-TGCC 
AGGAGTGAACCTGGAC-3′ and 5′-CCGAAGTGTGGTAGC 
GAGGA-3′ for P28; 5′-AGAGCCACAGAGCATGTCCAA-3′ 
and 5′-TGCACTCTGGGCTGGCTTAG-3′ for EBI3. The band 
sizes of the fragments were 125  bp (P28), 111  bp (EBI3), and 
149  bp (GAPDH). GAPDH was used as an internal control, 
and levels of each gene were normalized to GAPDH expression 
using the ΔΔCt-method. The identity of the amplified products 
was examined using agarose gel electrophoresis s and melt curve 
analysis.
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cytokine Measurement
The concentrations of IL-27 in serum and the lungs were 
measured by ELISA kits according to the manufacturer’s pro-
tocols (CUSABIO, Wuhan, China). All samples were assayed in 
duplicate.
cell isolation
Spleen cells suspension was obtained, as described above. Naive 
CD4+ T cells from suspensions of spleen were isolated by Naive 
CD4+ T Cell Isolation Kit (Miltenyi Biotec, Auburn, CA, USA) 
according to the manufacturer. Briefly, non-naive CD4+ T cells 
including cytotoxic T cells, Tregs, activated T cells, B cells, NK 
cells, macrophages, granulocytes, endothelial cells, and erythroid 
cells were indirectly magnetically labeled by using a cocktail 
of biotin-conjugated antibodies and Anti-Biotin MicroBeads. 
Memory T cells were directly magnetically labeled with CD44 
MicroBeads. Isolation of highly pure naive CD4+ T cells was 
achieved by depletion of magnetically labeled non-target cells. 
The purity of CD44low CD62L+ naive CD4+ T cells was >90%, as 
measured by flow cytometry.
effects of il-27 on the Differentiation  
of Th1 and Th17 cells In Vitro
Purified naive CD4+ T cells were plated in 24-well plates (Costar) 
at a density of 1 × 106 cells/ml in RPMI-1640 medium contain-
ing 10% FCS and were stimulated with plate-bound anti-CD3 
(5  mg/ml; 145-2C11; eBioscience, San Diego, CA, USA) and 
soluble anti-CD28 (2 mg/ml; 37.51; eBioscience). Th1 polarizing 
conditions as follow: IL-12 (20  ng/ml; eBioscience) and anti-
IL-4 (10 μg/ml; 11B11; eBioscience). For Th17 differentiation, 
cultures were supplemented with recombinant mouse IL-1β 
(10  ng/ml; Peprotech), IL-6 (20  ng/ml; eBioscience), IL-23 
(20  ng/ml; eBioscience), TGF-β (2  ng/ml; eBioscience), anti-
IL-4 mAb (10 μg/ml; 11B11; eBioscience), and anti-IFN-γ mAb 
(10  μg/ml; XMG1.2; eBioscience). Mouse recombinant IL-27 
(eBioscience) was added to some samples at different concentra-
tions (1–100 ng/ml). Cultures were also supplemented with IL-2 
(10 ng/ml; eBioscience) on days 2 and 4, refresh cells cultured 
with new medium and reagents on days 3. After cultured for 
6  days, some cells were harvested and stimulated with PMA 
(25  ng/ml; Sigma-Aldrich) and ionomycin (1  ng/ml; Sigma-
Aldrich) in the presence of GolgiPlug™ (BD Pharmingen) for 
4 h. The cells were subsequently stained with anti-IL-17 and anti-
IFN-γ mAbs. To intracellular stain with anti-T-bet (eBio4B10; 
eBioscience) and anti-ROR-γt (B2D; eBioscience), some cells 
were permeabilized with Foxp3/Transcription Factor Staining 
Buffer Set (eBioscience) strictly according to the manufacturer’s 
instructions.
For assessing the effects of IL-27 on the cells after Th1 and 
Th17 polarization, cultures were supplemented with IL-27 at 
different concentrations (1–100 ng/ml) on days 6 and cultured 
for 2 more days, the cells were harvested after stimulated with 
PMA and ionomycin and stained with anti-IL-17, anti-IFN-γ, 
anti-T-bet, and anti-ROR-γt mAbs, as described above.
signal Transductions of il-27 on Th1 and 
Th17 Differentiation
To examine the transcription factors involved in IL-27 regulating 
the differentiation of Th1 and Th17 cells, naive CD4+ T cells were 
stimulated at Th1 or Th17 polarization conditions, as described 
above. Three days later, the medium was supplemented with 
IL-27, and the cells were stimulated for 30 min and stained with 
PE-pSTAT1 (Tyr701), Alexa Fluor647 -pSTAT3 mAbs (Tyr705, 
all from Cell Signaling Technology, Inc., Danvers, MA, USA). 
Briefly, cells were fixed with 4% paraformaldehyde for 10  min 
at 37°C, permeabilized by incubate 30 min on ice with ice-cold 
100% methanol. Cells were then incubated with p-STAT1 and 
p-STAT3 mAbs for 1 h at room temperature. Flow cytometry was 
performed, as mentioned above.
effects of il-27 neutralization in  
cigarette smoke-exposed Mice
Mice were exposed to cigarette smoke for 24 weeks, as described 
above. The effect of IL-27 neutralization on mouse was examined 
by tail vein injection with anti-mouse IL-27 p28 functional grade 
purified mAbs (MM27-7B1; eBioscience) twice a week (10 μg in 
200 μl PBS per time) in the course of cigarette smoke exposure. 
Morphometry assay and cells collection were managed with 
procedure, as described above.
statistics
Data were expressed as mean ± SD. Differences between groups 
were compared unpaired Student’s t-test or one-way ANOVA. 
Correlations between variables were determined by Spearman’s 
rank correlation test. Analysis was completed using SPSS version 
16.0 Statistical Software (Chicago, IL, USA), and p <  0.05 was 
considered to indicate statistical significance.
resUlTs
elevated il-27 Was associated with 
increased expression of Th1 and Th17 
cells in Patients with cOPD
We first quantified the concentrations of serum IL-27 in patients 
with COPD using ELISA. Compared with non-smokers or healthy 
smokers, serum IL-27 was significantly elevated in patients with 
COPD (96.5 ± 36.8 and 107.4 ± 29.0 and 165.6 ± 46.0 pg/ml, 
respectively; p < 0.05). However, there was no significant differ-
ence between non-smokers and healthy smokers (Figure 1A). In 
addition, serum IL-27 concentrations were correlated negatively 
with FEV1 (% pred) in patients with COPD (Figure 1B).
Subsequently, we investigated the expression of Th1 and Th17 
cells in patients with COPD. Flow cytometry was performed 
on PBMCs with gating on CD4+ T lymphocytes (Figure S1A in 
Supplementary Material). The representative flow cytometric dot 
plots of Th1 and Th17 cells in peripheral blood were showed in 
Figure 2A. When compared with non-smokers or healthy smok-
ers, the percentages of Th1 cells showing a significant increase 
FigUre 1 | elevated expression serum levels of il-27 in patients with cOPD. (a) IL-27 protein concentrations in serum of non-smokers, healthy smokers, 
and COPD patients. Data are expressed as means ± SD. Horizontal bars indicate means. The comparisons were determined by one-way ANOVA. *p < 0.05 
compared with one another among three groups. (b) Correlation between serum IL-27 and FEV1 (% pred) in COPD patients. Correlations between two parameters 
were determined by Spearman’s rank correlation test.
FigUre 2 | increased expression of Th1 and Th17 cells in peripheral blood of cOPD patients. (a) Lymphocytes were identified based on their characteristic 
properties shown in the FSC and SSC, and CD4+ T cells were gated from lymphocytes. The representative flow cytometric dot plots of Th1 and Th17 cells in 
peripheral blood of non-smokers, healthy smokers, and COPD patients. FSC, forward scatter cytometry; SSC, sides scatter cytometry. (b) Comparisons of 
percentages of Th1 cells (c) and Th17 cells in non-smokers, healthy smokers, and COPD patients. Data are expressed as means ± SD. Horizontal bars indicate 
means. The comparisons were determined by one-way ANOVA (*p < 0.05). (D) Correlation between serum IL-27 and Th1 (e) and Th17 cells in COPD patients. 
Correlations between two parameters were determined by Spearman’s rank correlation test.
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in patients with COPD (Figure 2B). In addition, we noted that 
the frequencies of Th17 cells were significantly higher in COPD 
patients than in non-smokers or healthy smokers (Figure 2C). 
We also found that IL-17+IFN-γ+CD4+ T cells were significantly 
higher in COPD patients. Furthermore, the levels of serum IL-27 
in COPD patients were correlated positively with the percentages 
of Th1 cells (Figure 2D), suggesting functional involvement of 
IL-27 in regulating the differentiation of Th1 cells. However, there 
FigUre 3 | cigarette smoke exposure (cse) induced alveolar destruction and airspace enlargement in mice. Representative photomicrographs of 
hematoxylin and eosin-stained lung tissue of air-control and cigarette smoke-exposed mice at 24 weeks (magnification, ×200). (a) Air-control mice (b) cigarette 
smoke-exposed mice. The arrows in (a) indicate the normal alveolar and the lymphocytes in alveolar septa in air-control mice. The arrows in (b) represent the 
enlargement of the air spaces the destruction of the alveolar architecture accompanied by the infiltration of lymphocytes. (c) Comparisons of Lm values in air-control 
and cigarette smoke-exposed mice. n = 10 animals/group; data are expressed as means ± SD. The comparisons were determined by Student’s t-test.
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was no detectable correlation between serum IL-27 levels and the 
percentages of Th17 cells in peripheral blood of COPD patients 
(Figure 2E).
cigarette smoke exposure induced 
elevated il-27 expression in Mice
Because cigarette smoking is critical to the pathogenesis of COPD, 
we assessed IL-27 in a smoking mouse model of emphysema. The 
mice developed an emphysematous phenotype after 24 weeks of 
cigarette smoke exposure, showing enlargement of the air spaces 
accompanied by the destruction of the alveolar architecture. The 
representative morphometric results of the lungs after cigarette 
smoke exposure were presented in Figures 3A,B. To quantify the 
presence and severity of emphysema, we determined the enlarge-
ment of alveolar spaces by measuring the mean linear intercept 
(Lm). Compared with air-control mice (31.2 ± 1.6 μm), significant 
air space enlargement was observed in cigarette smoke-exposed 
mice (48.5 ± 3.1 μm, respectively; p < 0.0001) (Figure 3C).
We next detected the levels of IL-27 protein in cigarette 
smoke-exposed mice. The levels of IL-27 protein in blood and 
lung were measured with ELISA. Consistent with the results of 
COPD patients, we found that IL-27 protein was significantly 
upregulated in blood of mice after cigarette smoke exposure 
when compared with air-control mice. Similarly, the levels of 
IL-27 protein in lungs of cigarette smoke-exposed mice were also 
significantly higher than that of air-control (Figure 4A).
To further confirm our observations, the mRNA expression 
levels of p28 and EBI3 in blood and spleen and lung of cigarette 
smoke-exposed mice were quantified by quantitative RT-PCR. In 
tissues (blood, spleen, and lung) from cigarette smoke-exposed 
mice, we observed that the p28 mRNA expression was markedly 
higher than in air-control mice (Figure  4B). Similarly, there 
was a significant increase in EBI3 mRNA expression in tissues 
(blood, spleen, and lung) from cigarette smoke-exposed mice 
(Figure 4C).
cigarette smoke exposure induced 
Upregulated il-27r (WsX-1) expression  
in Mice
Given the critical importance of IL-27R (WSX-1) in IL-27 signal-
ing, we sought to investigate the expression of IL-27R (WSX-1) in 
FigUre 4 | elevated expression levels of il-27 in cigarette smoke-exposed mice. (a) IL-27 protein concentrations in serum, lungs of air-control and 
cigarette smoke-exposed mice. (b) IL-27 p28 mRNA (c) and EBI3 mRNA expression in peripheral blood, spleens, and lungs of air-control and cigarette smoke-
exposed mice. Data are expressed as means ± SD. The comparisons were determined by Student’s t-test (*p < 0.05).
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cigarette smoke-exposed mice. As shown in Figure 5A, we found 
IL-27R (WSX-1) was expressed on total CD4+ T cells, which 
consistent with previous studies. Yet, the expression of IL-27R 
(WSX-1) on subgroup of CD4+ T cells has not been elucidated 
in detail. We then examined the phenotype of CD4+ IL-27R+ 
T cells and found that most of the CD4+IL-27R+ T cells were 
CD44lowCD62L+naive CD4+ T cells, only a small proportion of 
CD44high CD62L− effector CD4+ T cells expressed IL-27R (data 
not shown). These results indicated that naive CD4+ T cells 
are the major target of IL-27 immune regulating function. We 
further examined the expression of IL-27R (WSX-1) on effector 
and naïve CD4+ T cells in cigarette smoke-exposed mice. Our 
result demonstrated that the expression of IL-27R (WSX-1) on 
effector CD4+ T cells did not show any differ between two group 
(Figures 5B,D). However, IL-27R (WSX-1) was notably upregu-
lated on naïve CD4+ T cells from cigarette smoke-exposed mice, 
as compared with air-control mice (Figures 5C,E).
The Phenotypic characteristics of cD4+ 
T cells and Proportions of Th1 and Th17 
cells in Mice of cigarette smoke exposure
Since elevated IL-27 was observed in mice of cigarette smoke 
exposure and IL-27R (WSX-1) was mainly expressed on naive 
CD4+ T cells, we interested in the phenotypic characteristics 
of CD4+ T cells after cigarette smoke exposure. As shown in 
Figures  6A,B, a significant decrease of CD44lowCD62L+ naive 
CD4+ T cells was observed in peripheral blood of cigarette smoke-
exposed mice when compared with air-control mice. In contrast, 
the percentages of CD44highCD62L− effector CD4+ T cells in 
peripheral blood were significantly increased after 24  weeks of 
cigarette smoke exposure (Figures  6A,C). Similar results were 
obtained in samples from spleens and lungs in cigarette smoke-
exposed mice (Figures  6A–C). Moreover, the percentages of 
CD44high CD62L+memory CD4+ T cells in peripheral blood and 
lungs of cigarette smoke-exposed mice were higher than that in 
air-control mice (Figure 6D).
It is well known that activated CD4+ T cells participate in the 
pathogenesis of COPD via producing IFN-γ and other related 
cytokines. Regarding the CD4+ T cells from mice of cigarette 
smoke exposure exhibited an activated phenotype of CD62Llow 
and CD44high, we next focused on the cytokines secreted by 
activated CD4+ T cells. Flow cytometry was performed on CD4+ 
T cells after intracellular stained with anti-IFN-γ and anti-
IL-17 mAbs (Figure  7A). In cigarette smoke-exposed mice, 
significant increases in both IFN-γ and IL-17 were observed 
in peripheral blood, spleens, and lungs compared with that in 
air-control mice (Figures 7B–D). Furthermore, the percentages 
of Th1 and Th17 cells in lungs of cigarette smoke-exposed mice 
were correlated positively with Lm (Figures 7E,F). These results 
collectively suggested that both Th1 and Th17 cells contribute 
to the pathogenesis of emphysema induced by cigarette smoke 
exposure.
il-27 induced Th1 but inhibited Th17 
Differentiation In Vitro
To explore the effects of IL-27 on the differentiation of Th1 and 
Th17 cells in vitro, naive CD4+ T cells were purified from mouse 
spleen and were cultured in Th1 or Th17 polarization conditions 
in the presence or absence of IL-27. Low to minimal IFN-γ and 
IL-17 was detected in naive CD4+ T cells before polarization. 
As presented in Figures  8A–C, via a dose-dependent manner, 
recombinant mouse IL-27 significantly enhanced the secretion 
of IFN-γ by CD4+ T cells in Th1 condition. Nevertheless, IL-27 
can effectively suppress the production of IL-17 by CD4+ T cells 
in Th17 condition, this effect also in a concentration-dependent 
way (Figure 8D). In addition, we noted that the production of 
IFN-γ by CD4+ T cells in Th17 condition was also elevated after 
the administration of IL-27, but the increase was no statistically 
significant (Figure 8B).
Although only a small minority of effector CD4+ T cells 
expressing IL-27R (WSX-1), IL-27 might exert an immuno-
logical effect on these cells. To address this possibility, naive 
FigUre 5 | increased expression of il-27r (WsX-1) on effector and naïve cD4+ T cells in cigarette smoke-exposed mice. (a) The representative flow 
cytometric dot plots of IL-27R (WSX-1) on total CD4+ T cells. The expression of IL-27R (WSX-1) on (b) CD44highCD62L−effector CD4+ T cells (c) and 
CD44lowCD62L+naïve CD4+ T cells in mice of air-control or cigarette smoke exposed. The comparison of IL-27R (WSX-1) expression on (D) effector CD4+ T cells 
(e) and naïve CD4+ T cells in peripheral blood, spleens, and lungs of air-control or cigarette smoke-exposed mice. NS, no difference. Data are expressed as 
means ± SD. The comparisons were determined by Student’s t-test (**p < 0.001).
8
Qiu et al. IL-27/WSX-1 Regulates Th1/Th17
Frontiers in Immunology | www.frontiersin.org December 2016 | Volume 7 | Article 553
FigUre 6 | Phenotypic characteristics of cD4+ T cells in cigarette smoke-exposed mice. (a) The representative flow cytometric dot plots of naïve 
(CD44lowCD62L+), memory (CD44highCD62L+), and effector (CD44highCD62L−) CD4+ T cells in peripheral blood, spleens, and lungs of air-control and cigarette 
smoke-exposed mice. (b) Comparisons of percentages of naïve CD4+ T cells (c) and effector CD4+ T cells (D) memory CD4+ T cells in air-control and cigarette 
smoke-exposed mice. Data are expressed as means ± SD. The comparisons were determined by Student’s t-test (*p < 0.01, **p < 0.001).
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CD4+ T cells were isolated and stimulated in Th1 or Th17 
polarization conditions. After cultured for 6 days, the activated 
cells were supplemented with recombinant mouse IL-27 and 
cultured for 2 more days. As shown in Figures 8E,F, IL-27 also 
promoted the production of IFN-γ by cells in Th1 condition 
but inhibited IL-17 by cells in Th17 condition via a dose-
dependent way.
expression of T-bet and rOr-γt during 
Differentiation of Th1 and Th17
Given T-bet and ROR-γt is the specific transcription factor of Th1 
and Th17, which involves in their development and functions. We 
examined the expression of T-bet and ROR-γt during differentia-
tion of Th1 and Th17 under the same polarization conditions. In 
agreement with the change in IFN-γ expression, supplement of 
IL-27 to cells under Th1 or Th17 condition significantly augmented 
the expression of T-bet (Figures  9A–D), whereas the addition 
of IL-27 to cells under Th17 condition markedly diminished the 
expression of ROR-γt (Figures 9B,E,F). Interestingly, we noted 
that about 10% of cells in Th1 conditions were expressed ROR-γt 
but only a minor fraction of T-bet was expressed on the cells in 
Th17 conditions (Figures 9D,E).
sTaT signals involved in the 
Differentiation of Th1 and Th17
We noted that STAT1 and STAT3 were both involved in the differ-
entiation of Th1 cells, and the addition of IL-27 triggered a rapid 
and significant increase in STAT1 and STAT3 phosphorylation 
FigUre 7 | increased proportions of Th1 and Th17 cells in cigarette smoke-exposed mice. (a) Lymphocytes were identified based on their characteristic 
properties shown in the FSC and SSC, and CD4+ T cells were gated from lymphocytes. The representative flow cytometric dot plots of Th1 and Th17 cells in 
peripheral blood, spleens, and lungs of air-control and cigarette smoke-exposed mice. (b) Comparisons of percentages of Th1 cells (c) and Th17 cells (D) 
IFN-γ+IL-17+CD4+ T cells in air-control and cigarette smoke-exposed mice. Data are expressed as means ± SD. The comparisons were determined by Student’s 
t-test (*p < 0.01, **p < 0.001). (e) Correlation between Lm and Th1 (F) and Th17 cells in lungs of cigarette smoke-exposed mice. Correlations between two 
parameters were determined by Spearman’s rank correlation test.
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(Figures  10A–C,E). Similar results were observed in the cells 
under Th17 conditions. Although the cells in Th17 condition with 
a higher extent of STAT3 activation (Figures 10B,F), supplement 
of IL-27 to mediums caused a significant increase in STAT1 
phosphorylation (Figures 10A,D).
effects of il-27 neutralization on cigarette 
smoke-exposed Mice
Finally, we determined the effects of anti-IL27 treatment on 
the development of Th1 and Th17 cells in  vivo. We injected 
anti-mouse IL-27 p28 functional grade purified mAbs into mice 
FigUre 8 | il-27 promoted the Th1 but inhibited the Th17 cells differentiation in vitro. (a) Naive CD4+ T cells from spleen of wild-type mice were cultured 
under Th1 and Th17 conditions in the presence or absence different concentrations of IL-27. The representative flow cytometric dot plots of Th1 and Th17 are 
showing from five independent experiments. (b) Comparisons of percentages of Th1 and Th17 cells in each group. The comparisons were determined by one-way 
ANOVA (*p < 0.05). (c,D) The effects of different concentrations of IL-27 on the cells under Th1 and Th17 conditions. (e,F) The effects of IL-27 on the cells after 
6 days stimulated in Th1 and Th17 condition.
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intravenously twice a week in the course of cigarette smoke 
exposure. We observed that the emphysema in mice receiving 
anti-IL-27 treatment was ameliorated to a certain extend as 
compared with which received PBS (Figure 11A). The total num-
ber of cells isolated from spleen and right lung were showed in 
Table 2. We confirmed the neutralization effect by measuring the 
FigUre 9 | effects of il-27 on expression of T-bet and rOr-γt during the differentiation of Th1 and Th17 cells. Naive CD4+ T cells from spleen of 
wild-type mice were cultured under Th1 and Th17 conditions in the presence or absence different concentrations of IL-27. (a,b) The representative flow cytometric 
histogram-plot of T-bet or ROR-γt are showing from five independent experiments. (c–F) Comparisons percentages of T-bet and ROR-γt in each group. The 
comparisons were determined by one-way ANOVA (*p < 0.05).
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concentrations of serum IL-27 in mice which received anti-IL-27 
treatment with ELISA (Figure S1C in Supplementary Material). 
As expected, anti-IL-27 treatment induced a higher proportion of 
naïve CD4+ T cells but a lower frequency of effector CD4+ T cells 
in cigarette smoke-exposed mice when compared with mice 
treating with PBS (Figures 11B,C). The proportion of memory 
CD4+ T cells was no statistical difference between two groups 
(Figure  11D). In addition, treatment with anti-IL-27 antibody 
attenuated the expression of Th1 cells in cigarette smoke-exposed 
mice (Figure 11E). However, the expression of Th17 cells in mice 
that treated with anti-IL-27 antibody was not significantly differ-
ent from that of control mice (Figure 11F).
DiscUssiOn
Chronic inflammation in the airways and the lung parenchyma 
which mainly triggered by cigarette smoke is the most remarkable 
characteristic of COPD. Th1 and Th17 cells have been considered 
to be key driver and effector cells in this chronic inflammatory 
procedure, but the immune regulation between these cells remains 
FigUre 10 | signal transductions involved in differentiation Th1 and Th17 cells. Naive CD4+ T cells from spleens of wild-type mice were cultured under Th1 
and Th17 conditions. Three days later, the medium was supplemented with different concentrations of IL-27 and the cells were stimulated for 30 min and 
intracellular stained with p-STAT1, p-STAT3. (a,b) The representative expression of p-STAT1, p-STAT3 in cells under Th1 and Th17 conditions in the presence or 
absence of IL-27. (c–F) Comparisons of percentages of p-STAT1, p-STAT3 in each group. The comparisons were determined by one-way ANOVA (*p < 0.05).
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elusive. Here, we demonstrated that elevated IL-27 was associ-
ated with increased expression of Th1 and Th17 cells in patients 
with COPD. In addition, cigarette smoke exposure dramatically 
upregulated the expression of IL-27R (WSX-1) by naive CD4+ 
T cells in a mouse model of emphysema. Furthermore, IL-27 
significantly augmented the secretion of IFN-γ but inhibited 
the production of IL-17 by naive CD4+ T  cells in  vitro. More 
importantly, anti-IL-27 treatment attenuated the expression of 
IFN-γ-producing CD4+ T cells in cigarette smoke-exposed mice. 
These results suggested that IL-27 regulates the development 
and differentiation of Th1 and Th17 cells and may be a reason 
responsible for the exaggerated Th1 response in COPD.
A large body of evidence has established that Th1 cells play a 
pivotal role in the pathogenesis of COPD. Recent literatures pro-
posed that Th17 cells may involve in the development and pro-
gression of the disease. In the present study, we observed Th1 and 
FigUre 11 | anti-il-27 treatment decreased the proportions of effector cD4+ T cells and downregulated the expression of Th1 cells in cigarette 
smoke-exposed mice. Mouse was treated by tail vein injection with anti-mouse IL-27 p28 functional grade purified mAbs twice a week (10 μg in 200 μl PBS per 
time) in the course of cigarette smoke exposure. (a) Comparisons of Lm values in cigarette smoke-exposed mice treated with anti-IL-27 antibody and in mice 
treated with PBS. (b) Comparisons of percentages of naive CD4+ T cells (c) and effector CD4+ T cells (D) and memory CD4+ T cells (e) and Th1 cells (F) and Th17 
cells in cigarette smoke-exposed mice treated with anti-IL-27 antibody and mice treated with PBS (each n = 8). Data are expressed as means ± SD. The 
comparisons were determined by Student’s t-test (*p < 0.05, **p < 0.001).
Table 2 | Total number cells of spleen and lung.
cse + Pbs (n = 8) cse + anti-il-27 (n = 8)
Spleen cells (×107) 11.76 ± 1.63 12.40 ± 1.51
Lung cells (×107) 2.86 ± 0.98 2.76 ± 0.86
Data are expressed as means ± SD.
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Th17 cells both were markedly increased in peripheral blood of 
COPD as compared with the healthy smokers and non-smokers. 
Consistent with Cao et al. reports (23), we showed that the pro-
tein level of IL-27 in serum was significantly elevated in COPD. 
In addition, the serum concentrations of IL-27 in COPD were 
correlated positively with the percentages of Th1 cells, suggesting 
a possible connection between IL-27 and these cells. Additionally, 
early studies have reported there are interesting parallels between 
Th1 and Th17 lineage developmental programs. In this regard, it 
is possible to predict IL-27 might exert potential effect on Th17 
cells differentiation. But the underlying mechanisms by which 
IL-27 regulation of Th1 and Th17 cells in smoking-related COPD 
still unknown.
By employing a mouse model of emphysema induced by 
cigarette smoking, we achieved results similar to COPD 
patients that not only IL-27 protein but also p28 and EBI3 
mRNA expression was notably upregulated in mice after 
cigarette smoke exposure. IL-27 executes its function through 
binding to its receptor complex (IL-27R). There were reports 
documented that WSX-1 mRNAs was markedly upregulated 
within the brain lesions of postmortem multiple sclerosis 
or in inflammatory cells in the CNS during EAE (19, 25). 
Additionally, Villarino and colleagues found that the expres-
sion of WSX-1 was increased during acute toxoplasmosis (26). 
But to the best of our knowledge, there were no data available 
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so far concerning the expression of IL-27R in cigarette smoke-
exposed mice. In the current study, our results revealed that 
WSX-1 was mainly expressed on naive but not effector or 
memory CD4+ T cells in line with previous reports (data no 
shown), implying that naïve CD4+ T cells were the major target 
of IL-27 action within the smoking induced inflammation. 
Importantly, we demonstrated for the first time that IL-27R 
(WSX-1) was upregulated on naïve CD4+ T cells in the setting 
of cigarette smoke-induced emphysema, which absence on 
effector T cells. In view of this, it was plausible to conclude that 
the upregulation of IL-27 and IL-27R on naïve CD4+ T  cells 
could render naive CD4+ T cells differentiate into a specific 
T cell linage in the stimulation of cigarette smoke. As expect, we 
observed a majority of CD4+ T cells in mice of cigarette smoke 
exposure displayed the phenotype of effector and memory cells. 
Moreover, a considerable increase of IFN-γ and IL-17 in CD4+ 
T cells was found after cigarette smoke exposure. Therefore, 
these findings gave rise to speculation that IL-27 triggered by 
cigarette smoke exposure might interact with IL-27R on naive 
CD4+ T cells, thus contribute to naive CD4+ T cells differentiate 
into IFN-γ-producing effector CD4+ T cells in smoking mouse 
model of emphysema.
IL-27 has been found to possess pro- and anti-inflammatory 
activity and play an essential role during the pathogenesis of 
infectious and autoimmune diseases (27–30), but its functions 
in chronic inflammatory disease remain controversial. The 
initial reports described IL-27 as a promoter of Th1 polarization 
and IFN-γ production of naive CD4+ T cells (12). In contrast, 
recent studies found that IL-27 receptor signaling exerted its 
anti-inflammatory activities by preventing Th1-mediated immu-
nopathology during T. gondii and malaria infection (18, 31–33). 
In addition, there were reports showed that IL-27 negatively 
regulated the development of Th17 during chronic inflammation 
of the central nervous system in mice that chronically infected 
with T. gondii, or in mice that coxsackievirus-B3-induced viral 
myocarditis (20, 21, 34). In light of substantially increased IL-27 
in the mice after cigarette smoke exposure, we investigated the 
role of IL-27 in the differentiation of Th1 and Th17 cells in vitro. 
The result demonstrated that via a dose-dependent manner, 
recombinant mouse IL-27 significantly promoted the secretion 
of IFN-γ but inhibited the production of IL-17 by naive CD4+ 
T cells in Th1 conditions or in Th17 conditions. In addition, we 
noted that even in cells that had been committed in Th1 or Th17 
lineage in which TCCR expression was substantially diminished; 
IL-27 still remained functions for enhancing the Th1 differentia-
tion and depressing Th17 differentiation. Since previous studies 
focused on the effects of IL-27 on naive CD4+ T cells, this obser-
vation may expand the role of IL-27 in other subgroup of CD4+ 
T cells. These data collectively identified a dominant function for 
IL-27 in the induction of Th1 response from naive CD4+ T cells 
in vitro, and the potential effect of IL-27 on antagonizing Th17 
response.
T-bet is the specific transcription factor, which programs the 
differentiation of Th1 cells and ROR-γt, is the key transcription 
factor that orchestrates the differentiation of Th17 cells. Earlier 
researches have discovered that IL-27 induced the expression 
of T-bet during initial Th1 commitment but blocked ROR-γt 
expression to inhibit the lineage commitment of Th17 cells (35, 
36). In agreement with previous studies, we found IL-27 signifi-
cantly augmented T-bet expression by naive CD4+ T cells in Th1 
conditions or in Th17 conditions. In contrast, the expression of 
ROR-γt was dramatically suppressed by the addition of IL-27 
in Th1 conditions or in Th17 conditions. Th17 cells appeared 
to have greater plasticity in their late stages of development, 
which stimulated with IL-12 induced a rapid transition of IFN-γ 
expression via a STAT4- and T-bet-dependent manner, whereas 
Th1 cells are more resistant to transition to a Th17 cytokine-
expression pattern (37–39). In this study, as the presence of 
IL-17+IFN-γ+CD4+ T  cells, we observed the coexpression of 
T-bet and ROR-γt in cells whatever under Th1 condition or 
Th17 condition, suggesting there are parallels between the 
developmental programs of Th1 and Th17 cells. Stimulation of 
cells under Th17 conditions with IL-27, leading to an increase 
expression of T-bet accompanied by the excessive secretion of 
IFN-γ. However, the cells already polarized to Th17 without 
shifted their phenotype toward enhanced IFN-γ production 
in the presence of IL-27 alone. Further studies are needed to 
address the impact of the combination of IL-27 with IL-12 on the 
transition of Th17 to IFN-γ secretion pattern; given that IL-27 
and IL-12 are abundant in COPD.
Although the activation of STAT1 was linked with IL-27-
induced Th1 polarization (35, 40), our data provided evidence 
that STAT3 was also participated in this procedure. In the 
current study, both p-STAT1 and p-STAT3 were increased by 
the addition of IL-27 into cells under Th1 condition, which 
in line with the expression of T-bet and IFN-γ, suggesting 
the activation of STAT1 and STAT3 are all mediating T-bet 
induction in the course of IL-27 initiated Th1 commitment. 
This result is in agreement with a study by Jung et al., which 
found that elevated IL-27 levels in primary human neonatal 
macrophages regulated indoleamine dioxygenase in a STAT-1 
and STAT-3-dependent manner (41). Activation of STAT3 
by IL-6 and IL-23 drives the production of IL-17 by CD4+ T 
cells. Nevertheless, the function of IL-27 on inhibition of IL-17 
production by CD4+ T cells was substantial compromised in 
absence of STAT1 (21). As shown in this study, we found that 
p-STAT3 was predominating in Th17 conditions, whereas the 
addition of IL-27 elicited a pronounced increase of p-STAT1, 
but not p-STAT3. This observation supported the idea that 
phosphorylation of STAT1-mediates inhibition activity of 
IL-27 to Th17 cells.
It has been reported that IL-27 plays an anti-inflammatory 
role in septic mice and contributes to the sepsis-induced 
immuno-suppression, blockading the biological function of 
IL-27 results in increased survival and reduces the susceptibility 
to secondary P. aeruginosa infection (42, 43). However, in con-
trast to the findings in sepsis, the increased expression of IL-27 
in COPD was accompanied with an amplified, uncontrolled 
chronic inflammatory response, suggesting a pro-inflammatory 
activity of IL-27 in this context. Thus, we assessed the poten-
tial effects of neutralizing the biological function of IL-27 in 
cigarette smoke-exposed mice. We observed that anti-IL-27 
treatment effectively decreased Th1-mediated inflammation 
in cigarette smoke-exposed mice. Interestingly, there was no 
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significant difference in Th17 cells expression between mice 
treating with anti-IL-27 antibody and mice treating with PBS. 
Despite the inhibitory activity of IL-27 on the secretion of IL-17 
by naive CD4+ T cells in vitro, IL-27 neutralization did not lead 
to a more exaggerated IL-17 production in smoking mouse 
model of emphysema. It seems that there are other mediators 
antagonize Th17 response or the residual IL-27, which have not 
been extinguished by anti-IL-27 treatment still exerts fully func-
tion on Th17 cells. Therefore, further studies (e.g., using IL-27R 
alpha/WSX-1−/− mice model) are needed to determine the role 
of IL-27 on Th17 cells in vivo.
In conclusion, here, we have demonstrated that IL-27 was 
elevated in patients with COPD and in a mouse model of 
emphysema. In addition, cigarette smoke exposure induced 
the upregulation of IL-27R (WSX-1) by naive CD4+ T cells 
in cigarette smoke-exposed mice. IL-27 has the function 
for promoting the expression of Th1 cells but inhibiting the 
expression of Th17 cells in  vitro. In vivo, IL27 neutralization 
significantly attenuated Th1-mediated inflammation. Thus, our 
findings contribute to a better understanding of pathogenesis of 
emphysema induced by cigarette smoke exposure, and target-
ing IL-27/WSX-1 may provide a new therapeutic approach for 
COPD.
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